| Sudhir Bansal, MD | |
|
215 Tollgate Road, Suite 309/310, Warwick, RI 02886-4456 | |
| (401) 732-6828 | |
| (401) 223-3040 |
| Full Name | Sudhir Bansal |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 215 Tollgate Road, Warwick, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356373633 | NPI | - | NPPES |
| 119020098 | Other | MEDICARE PIN | |
| CPG002461001 | Other | BLUE CHIP | |
| 050461074 | Other | UHC | |
| 0000020098001 | Other | BC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 7603 (Rhode Island) | Primary |
| Entity Name | Sudhir Bansal, Md Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932424645 PECOS PAC ID: 2062671563 Enrollment ID: O20120301000632 |
News Archive
Local physicians from Tri-Valley Medical Group recently spent a week in Washington D.C. to discuss the fundamental issues impacting the roll-out of health care reform - and came away with a new appreciation of its challenges.
The search is over for self-help book enthusiasts who have been looking for that "one book" which reveals the most powerful information on the law of attraction and the exact steps on how to apply it.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) vaccine company, will collaborate with the Gynecologic Oncology Group (GOG), a collaborative research group of the National Cancer Institute (NCI), in a multicenter, Phase II clinical trial of the Company's lead drug candidate, ADXS11-001 in the treatment of advanced cervix cancer in women who have failed prior cytotoxic therapy.
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sudhir Bansal, MD 215 Tollgate Road, Suite 309/310, Warwick, RI 02886-4456 Ph: (401) 732-6828 | Sudhir Bansal, MD 215 Tollgate Road, Suite 309/310, Warwick, RI 02886-4456 Ph: (401) 732-6828 |
News Archive
Local physicians from Tri-Valley Medical Group recently spent a week in Washington D.C. to discuss the fundamental issues impacting the roll-out of health care reform - and came away with a new appreciation of its challenges.
The search is over for self-help book enthusiasts who have been looking for that "one book" which reveals the most powerful information on the law of attraction and the exact steps on how to apply it.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) vaccine company, will collaborate with the Gynecologic Oncology Group (GOG), a collaborative research group of the National Cancer Institute (NCI), in a multicenter, Phase II clinical trial of the Company's lead drug candidate, ADXS11-001 in the treatment of advanced cervix cancer in women who have failed prior cytotoxic therapy.
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.
› Verified 4 days ago
Dr. Sterling Leaf Malish, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 | |
Dr. John David Lowney, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1030 Warwick Ave, Warwick, RI 02888 Phone: 401-467-6257 Fax: 401-785-1191 | |
Dr. Christian Rene Herard, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 300 Tollgate Road, Suite 302, Warwick, RI 02886 Phone: 401-738-4014 Fax: 401-738-4090 | |
John A Gelzhiser, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 Fax: 401-736-4265 | |
Dr. Michael Seidler, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-921-9202 Fax: 401-921-9212 | |
Murli K Raman, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 455 Tollgate Rd, Brigham & Women's Cardiovascular Associates At Cne, Warwick, RI 02886 Phone: 401-681-4996 Fax: 401-921-6569 | |
Dr. Jennifer F Jarbeau, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 400 Bald Hill Rd Ste 524, Warwick, RI 02886 Phone: 401-737-7313 Fax: 401-737-4207 |